Chemical formula: C₉H₁₄N₄O₄ Molecular mass: 242.235 g/mol PubChem compound: 5353788
Molsidomine is a long acting vasodilating drug. Molsidomine, a sydnonimine acting as a heterocyclic direct nitric oxide donor, has been used for the treatment of patients with stable angina pectoris. It’s also established drug for the treatment of coronary heart disease. Molsidomine is metabolized in the liver to the active metabolite linsidomine. Linsidomine is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01DX12 | Molsidomine | C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DX Other vasodilators used in cardiac diseases |
Molsidomine is an active ingredient of these brands:
Austria (AT)France (FR)Germany (DE)Spain (ES)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
